semaglutide review Exploring beyond numeric weight loss: The metabolic effects of GLP-1 drugs such as semaglutide

Lixisenatide In the ELIXA (Evaluation of Lixisenatide in Acute Coronary Syndrome) study, T2D patients with a recent coronary artery event were randomly assigned (1:1) to a lixisenatide (1020 g) group or placebo group ( Albiglutide Harmony outcomes was a double-blind trial that included a total of 9,463 T2D participants of 40 years of age and a history of CVD, who were allocated to an albiglutide (3050 mg weekly) group or placebo group ( Renoprotection of GLP-1RAs is Largely Dependent on Reduction of Albuminuria As described above, GLP-1RAs have no clinically important effect on eGFR and hard renal endpoints

Note that both IGF-1 LR3 and IGF DES 1,3 are prohibited by World Anti-Doping Agency and use can have serious consequences for competitive athletes

PMCID: PMC5601071

Those who start to use GLP-1 peptides may experience

Combine with an injection tracker for full coverage

Staying hydrated and eating fiber-rich foods aids in managing this side effect